Table 3.
Baseline HbA1c Treated as Continuous Variable and Vein Graft Outcome 1 Year After CABG
| 1-Year Outcome | Patency (FitzGibbon Grade A) |
Nonocclusion (FitzGibbon Grade A+B) |
||
|---|---|---|---|---|
| OR Adjusted for Nonpatency (95% CI) | P Value | OR Adjusted for Occlusion (95% CI) | P Value | |
| Per graft | 1.25 (1.08–1.45) | 0.003 | 1.25 (1.07–1.46) | 0.004 |
| Per patient | 1.29 (1.10–1.52) | 0.002 | 1.26 (1.07–1.48) | 0.007 |
CI = confidence interval; HbA1c = glycated hemoglobin; OR = odds ratio, OR was adjusted for age, sex, medical history of hypertension and hyperlipidemia, SYNTAX score, target vessel distribution, antiplatelet therapy, and statin use at 1 year after coronary artery bypass graft; SYNTAX = Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery.